Research Team Finds TTK Inhibitor Kills Lung Cancer Cells and Tumors in Mice
December 14, 2019
December 14, 2019
FREDERICK, Maryland, Dec. 14 -- The National Institutes of Health's Frederick National Laboratory for Cancer Research issued the following news:
High levels of the enzyme tyrosine threonine kinase (TTK) in many types of cancer cells, including lung cancer, contribute to uncontrolled cell growth. A study published by Frederick National Laboratory Director Ethan Dmitrovsky, M.D. and his laboratory team demonstrated that a promising anti-TTK treatment that acts against many of those ty . . .
High levels of the enzyme tyrosine threonine kinase (TTK) in many types of cancer cells, including lung cancer, contribute to uncontrolled cell growth. A study published by Frederick National Laboratory Director Ethan Dmitrovsky, M.D. and his laboratory team demonstrated that a promising anti-TTK treatment that acts against many of those ty . . .